Document is current
Any future updates will be listed below
-
Authors
Gieselmann, Lutz
DeLaitsch, Andrew T. https://orcid.org/0000-0002-3458-3449
Rohde, Malena
Radford, Caelan
Worczinski, Johanna
Ashurov, Anna
Ahmadov, Elvin
Burger, Judith A.
Havenar-Daughton, Colin https://orcid.org/0000-0002-2880-3927
Deshpande, Sharvari
Giovannoni, Federico
Corti, Davide https://orcid.org/0000-0002-5797-1364
Kreer, Christoph https://orcid.org/0000-0002-9140-9850
Ercanoglu, Meryem Seda
Schommers, Philipp https://orcid.org/0000-0003-3375-6800
Georgiev, Ivelin S.
West, Anthony P. Jr. https://orcid.org/0000-0003-4213-5184
Knüfer, Jacqueline
Stumpf, Ricarda
Kroidl, Arne https://orcid.org/0000-0003-3569-9176
Geldmacher, Christof
Maganga, Lucas
William, Wiston
Ntinginya, Nyanda E.
Hoelscher, Michael https://orcid.org/0000-0002-7642-1835
Yang, Zhengrong
Wei, Qing
Renfrow, Matthew B.
Green, Todd J.
Novak, Jan https://orcid.org/0000-0002-9211-6670
van Gils, Marit J. https://orcid.org/0000-0003-3422-8161
Gristick, Harry B.
Gruell, Henning https://orcid.org/0000-0002-0725-7138
Bloom, Jesse D. https://orcid.org/0000-0003-1267-3408
Seaman, Michael S.
Bjorkman, Pamela J. https://orcid.org/0000-0002-2277-3990
Klein, Florian https://orcid.org/0000-0003-1376-1792
- License Information
-
More Information
Article History
Received: 15 May 2025
Accepted: 27 November 2025
First Online: 3 February 2026
Competing interests
: A patent application (Germany Patent application no. EP23203598) incorporating elements of this study has been submitted by the University of Cologne, with L.G. and F.K. listed as inventors. Additionally, H.G., P.S. and F.K. are named inventors on other patent applications related to HIV-1 neutralizing antibodies. L.G., H.G., P.S. and F.K. have received financial compensation from the University of Cologne for licensed patents. C.H.D, S.D, F.G. and D.C. are employees and stockholders of Vir Biotechnology. J.D.B. and C.R. are inventors on patents related to viral deep mutational scanning, licensed by Fred Hutch. J.D.B. also serves as a consultant for Apriori Bio. M.B.R. and J.N. are co-founders and co-owners of Reliant Glycosciences. The other authors declare no competing interests.
